Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 2/20 | 0.60 |
| ▸ | FNTB | P49356 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.60 |
| ▸ | CES1 | P23141 | 2/20 | 0.55 |
| ▸ | CES2 | O00748 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 6/20 | 0.48 |
| ▸ | PPARD | Q03181 | 6/20 | 0.48 |
| ▸ | PPARA | Q07869 | 6/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL180491 | 1.00 | FNTA (0.60) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL180490 | 1.00 | FNTA (0.60) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL3273113 | 0.97 | FNTA (0.58) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL4021292 | 0.95 | FNTA (0.68) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL4795567 | 0.92 | FNTA (0.54) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL9816496 | 0.92 | FNTA (0.72) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL20564044 | 0.92 | FNTA (0.54) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL9816500 | 0.92 | FNTA (0.72) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL4795561 | 0.92 | FNTA (0.54) | FNTAFNTBTHRBPGGT1BCES1 | |
| SCHEMBL555050 | 0.92 | FNTA (0.71) | FNTAFNTBTHRBPGGT1BCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 638 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630661-B2 | Additives useful in 3D printing technologies | Evonik Operations GmbII (DE) | 2026-05-19 | — | — | US | claimed |
| EP-4077489-B1 | POLYACRYLATE-BASED GRAFT COPOLYMER | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2026-03-11 | — | — | EP | claimed |
| EP-4017840-B1 | FAST PREPARATION OF LOW PRIMARY AMINE CONTAINING POLYASPARTIC ESTERS AND USE OF THESE POLYASPARTIC ESTERS IN SLOW REACTIVITY POLYUREA SYSTEMS | COVESTRO LLC (US) | 2024-09-25 | — | — | EP | claimed |
| EP-3894017-B1 | POLYMER BLEND FOR PERSONAL CARE FORMULATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-28 | — | — | EP | claimed |
| US-20230120872-A1 | ADDITIVES USEFUL IN 3D PRINTING TECHNOLOGIES | EVONIK OPERATIONS GMBH (DE) | 2023-04-20 | — | — | US | claimed |
| EP-4166332-A1 | ADDITIVES USEFUL IN 3D PRINTING TECHNOLOGIES | Evonik Operations GmbH (DE) | 2023-04-19 | — | — | EP | claimed |
| US-20220105064-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | BIOGEN SWISS MFG GMBH (CH) | 2022-04-07 | — | — | US | claimed |
| US-20220079884-A1 | PHARMACEUTICAL FORMULATION COMPRISING ONE OR MORE FUMARIC ACID ESTERS IN AN EROSION MATRIX | BIOGEN SWISS MFG GMBH (CH) | 2022-03-17 | — | — | US | claimed |
| US-11229619-B2 | Controlled release pharmaceutical compositions comprising a fumaric acid ester | BIOGEN SWISS MANUFACTURING GMBH (CH) | 2022-01-25 | — | — | US | claimed |
| EP-3110867-B1 | COATING COMPOSITIONS COMPRISING DIISOCYANATE CHAIN EXTENDED BISASPARTATES | COATINGS FOREIGN IP CO LLC (US) | 2021-10-06 | — | — | EP | claimed |
| US-5021490-A | Using reactive polyester | THE B. F. GOODRICH COMPANY (US) | 1991-06-04 | — | — | US | claimed |
| EP-0411514-A2 | Internally plasticized polyvinyl-halide compositions and articles prepared therefrom | The Geon Company (US) | 1991-02-06 | — | — | EP | claimed |
| EP-0165579-B1 | VINYL CHLORIDE RESIN COMPOSITION AND MEDICAL INSTRUMENT | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION (JP) | 1990-08-29 | — | — | EP | claimed |
| EP-0161804-B1 | METHOD FOR MODIFYING THE SURFACE OF POLYMER MATERIALS | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1990-08-01 | — | — | EP | claimed |
| EP-0183552-B1 | A PHOTOPOLYMERIZABLE COMPOSITION | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1988-03-16 | — | — | EP | claimed |
| EP-0073485-B1 | REINFORCEMENT PROMOTERS FOR FILLED THERMOPLASTIC POLYMERS | UNION CARBIDE CORPORATION (US) | 1987-05-20 | — | — | EP | claimed |
| EP-0073064-B1 | FILLED ORGANIC POLYMERIC COMPOSITIONS AND A MIXTURE FOR PREPARING SAID COMPOSITIONS | UNION CARBIDE CORPORATION (US) | 1987-04-01 | — | — | EP | claimed |
| EP-0073065-B1 | SYNERGISTIC REINFORCEMENT PROMOTER SYSTEMS FOR FILLED POLYMERS | UNION CARBIDE CORPORATION (US) | 1985-12-11 | — | — | EP | claimed |
| EP-0039756-B1 | PREPARATION OF POLYOXYALKYLENE SURFACTANTS FOR THE STABILISATION OF PHENOLIC FOAM, OPTIONALLY IN THE PRESENCE OF A METAL CATALYST | Celotex Corporation (US) | 1985-07-03 | — | — | EP | claimed |
| US-4154713-A | PAPER COATING BINDERS | FORSTNER JOSEF (AT) | 1979-05-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630661-B2 | Additives useful in 3D printing technologies | HTR3D, HTR3B, HTR3C | FNTA 4470/4885FNTB 2650/4885THRB 147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.